appie, with this possible UNGS/Sylios DD presented…
This due diligence (DD) that you have provided could be the key to understanding why UNGS had elected to go with Plan B, as we would like to call things. I’m leaning towards this deal being better than the previous deal with Signifi. Thanks for sharing as I will explain what I think might hold merit as more to add to what you have shared.
… of which I’m guessing through their Licensing Agreement with Artemis Dispensing Technologies… http://www.artemisvending.com/
… of which to now consider the Sylios/UNGS slideshow towards the bottom of the link below on Slide # 6 where it was stated this below…
The above piece mentioned within the slideshow above on the Sylios/UNGS website is the connection that might hold some merit. The Artemis connection above is the only ”Biometrics” connection that I have seen to be related to any of the companies I have come across from doing my DD on companies that are called Artemis. Although the stars appear to be slowly aligning, please only consider this to be speculation for now until more details are released from the company. I would consider the above to be only… food for thought.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.